Suchergebnisse - (Subject:"Heparin, Low-Molecular-Weight")

PubPharm (48)

1

A multi-national trial of a direct oral anticoagulant in children with cardiac disease : Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study

enthalten in: American heart journal | 2019

von Payne, R. | Burns, K. | Glatz, A. | +8

2

The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention

enthalten in: American heart journal | 2014

von Wang, T. | Magid, D. | Ting, H. | +4

3

Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure : a subgroup analysis of the randomized, controlled CERTIFY study

enthalten in: American heart journal | 2011

von Tebbe, U. | Schellong, S. | Haas, S. | +5

4

Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trial

enthalten in: American heart journal | 2009

von Melloni, C. | Fier, I. | Roach, J. | +7

5

The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial : study design and rationale

enthalten in: American heart journal | 2008

von Mehran, R. | Brodie, B. | Cox, D. | +10

6

Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials

enthalten in: American heart journal | 2007

von De Luca, G. | Marino, P.

7

Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study : rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)

enthalten in: American heart journal | 2007

von Enden, T. | Sandvik, L. | Kløw, N. | +8

8

Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs

enthalten in: American heart journal | 2007

von Steinhubl, S. | Kastrati, A. | Berger, P.

9

Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)

enthalten in: American heart journal | 2007

von Brieger, D. | Van de Werf, F. | Avezum, A. | +7

10

Enoxaparin versus tinzaparin in non-ST-segment elevation acute coronary syndromes : results of the enoxaparin versus tinzaparin (EVET) trial at 6 months

enthalten in: American heart journal | 2005

von Katsouras, C. | Michalis, L. | Papamichael, N. | +5

CommentIn: Evid Based Cardiovasc Med. 2006 Mar;10(1):30-1. - PMID 16530671

1
2
3
4
5
Nächster »
[5]